UniProt ID | PDE3A_HUMAN | |
---|---|---|
UniProt AC | Q14432 | |
Protein Name | cGMP-inhibited 3',5'-cyclic phosphodiesterase A | |
Gene Name | PDE3A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1141 | |
Subcellular Localization |
Membrane Multi-pass membrane protein . |
|
Protein Description | Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes.. | |
Protein Sequence | MAVPGDAARVRDKPVHSGVSQAPTAGRDCHHRADPASPRDSGCRGCWGDLVLQPLRSSRKLSSALCAGSLSFLLALLVRLVRGEVGCDLEQCKEAAAAEEEEAAPGAEGGVFPGPRGGAPGGGARLSPWLQPSALLFSLLCAFFWMGLYLLRAGVRLPLAVALLAACCGGEALVQIGLGVGEDHLLSLPAAGVVLSCLAAATWLVLRLRLGVLMIALTSAVRTVSLISLERFKVAWRPYLAYLAGVLGILLARYVEQILPQSAEAAPREHLGSQLIAGTKEDIPVFKRRRRSSSVVSAEMSGCSSKSHRRTSLPCIPREQLMGHSEWDHKRGPRGSQSSGTSITVDIAVMGEAHGLITDLLADPSLPPNVCTSLRAVSNLLSTQLTFQAIHKPRVNPVTSLSENYTCSDSEESSEKDKLAIPKRLRRSLPPGLLRRVSSTWTTTTSATGLPTLEPAPVRRDRSTSIKLQEAPSSSPDSWNNPVMMTLTKSRSFTSSYAISAANHVKAKKQSRPGALAKISPLSSPCSSPLQGTPASSLVSKISAVQFPESADTTAKQSLGSHRALTYTQSAPDLSPQILTPPVICSSCGRPYSQGNPADEPLERSGVATRTPSRTDDTAQVTSDYETNNNSDSSDIVQNEDETECLREPLRKASACSTYAPETMMFLDKPILAPEPLVMDNLDSIMEQLNTWNFPIFDLVENIGRKCGRILSQVSYRLFEDMGLFEAFKIPIREFMNYFHALEIGYRDIPYHNRIHATDVLHAVWYLTTQPIPGLSTVINDHGSTSDSDSDSGFTHGHMGYVFSKTYNVTDDKYGCLSGNIPALELMALYVAAAMHDYDHPGRTNAFLVATSAPQAVLYNDRSVLENHHAAAAWNLFMSRPEYNFLINLDHVEFKHFRFLVIEAILATDLKKHFDFVAKFNGKVNDDVGIDWTNENDRLLVCQMCIKLADINGPAKCKELHLQWTDGIVNEFYEQGDEEASLGLPISPFMDRSAPQLANLQESFISHIVGPLCNSYDSAGLMPGKWVEDSDESGDTDDPEEEEEEAPAPNEEETCENNESPKKKTFKRRKIYCQITQHLLQNHKMWKKVIEEEQRLAGIENQSLDQTPQSHSSEQIQAIKEEEEEKGKPRGEEIPTQKPDQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
62 | Phosphorylation | LRSSRKLSSALCAGS HHCCCHHHHHHHHHH | 19.32 | 24719451 | |
63 | Phosphorylation | RSSRKLSSALCAGSL HCCCHHHHHHHHHHH | 35.38 | 24719451 | |
69 | Phosphorylation | SSALCAGSLSFLLAL HHHHHHHHHHHHHHH | 11.43 | 22210691 | |
71 | Phosphorylation | ALCAGSLSFLLALLV HHHHHHHHHHHHHHH | 18.62 | 24719451 | |
96 | Ubiquitination | LEQCKEAAAAEEEEA HHHHHHHHHHHHHHH | 14.32 | 29967540 | |
145 | Ubiquitination | SLLCAFFWMGLYLLR HHHHHHHHHHHHHHH | 3.57 | 21963094 | |
146 | Ubiquitination | LLCAFFWMGLYLLRA HHHHHHHHHHHHHHH | 1.93 | 21963094 | |
167 | Ubiquitination | AVALLAACCGGEALV HHHHHHHHHCCHHHH | 1.52 | 21963094 | |
168 | Ubiquitination | VALLAACCGGEALVQ HHHHHHHHCCHHHHH | 7.23 | 21963094 | |
184 | Ubiquitination | GLGVGEDHLLSLPAA CCCCCCCCCHHCCHH | 25.11 | 29967540 | |
196 | Ubiquitination | PAAGVVLSCLAAATW CHHHHHHHHHHHHHH | 8.76 | 29967540 | |
218 | Phosphorylation | GVLMIALTSAVRTVS HHHHHHHHHHHHHHH | 12.96 | 24043423 | |
219 | Phosphorylation | VLMIALTSAVRTVSL HHHHHHHHHHHHHHH | 26.14 | 24043423 | |
219 | Ubiquitination | VLMIALTSAVRTVSL HHHHHHHHHHHHHHH | 26.14 | 29967540 | |
223 | Phosphorylation | ALTSAVRTVSLISLE HHHHHHHHHHHHCHH | 14.09 | 23403867 | |
225 | Phosphorylation | TSAVRTVSLISLERF HHHHHHHHHHCHHHH | 21.26 | 23403867 | |
228 | Phosphorylation | VRTVSLISLERFKVA HHHHHHHCHHHHHHH | 29.48 | 20860994 | |
234 | Ubiquitination | ISLERFKVAWRPYLA HCHHHHHHHHHHHHH | 5.93 | 29967540 | |
273 | Phosphorylation | APREHLGSQLIAGTK CCHHHHHCCHHCCCH | 28.33 | 28555341 | |
279 | Phosphorylation | GSQLIAGTKEDIPVF HCCHHCCCHHHCCHH | 23.41 | 22210691 | |
287 | Ubiquitination | KEDIPVFKRRRRSSS HHHCCHHHHCCCCCC | 45.27 | 29967540 | |
292 | Phosphorylation | VFKRRRRSSSVVSAE HHHHCCCCCCCCEEE | 25.75 | 25884760 | |
293 | Phosphorylation | FKRRRRSSSVVSAEM HHHCCCCCCCCEEEC | 25.91 | 21712546 | |
294 | Phosphorylation | KRRRRSSSVVSAEMS HHCCCCCCCCEEECC | 27.99 | 21712546 | |
297 | Phosphorylation | RRSSSVVSAEMSGCS CCCCCCCEEECCCCC | 19.16 | 29396449 | |
301 | Phosphorylation | SVVSAEMSGCSSKSH CCCEEECCCCCCCCC | 28.31 | 29396449 | |
304 | Phosphorylation | SAEMSGCSSKSHRRT EEECCCCCCCCCCCC | 44.31 | 25954137 | |
305 | Phosphorylation | AEMSGCSSKSHRRTS EECCCCCCCCCCCCC | 42.10 | 25954137 | |
311 | Phosphorylation | SSKSHRRTSLPCIPR CCCCCCCCCCCCCCH | 34.27 | 25463755 | |
312 | Phosphorylation | SKSHRRTSLPCIPRE CCCCCCCCCCCCCHH | 28.62 | 22167270 | |
399 | Phosphorylation | KPRVNPVTSLSENYT CCCCCCCCCCCCCCC | 25.80 | 29632367 | |
400 | Phosphorylation | PRVNPVTSLSENYTC CCCCCCCCCCCCCCC | 30.08 | 29632367 | |
402 | Phosphorylation | VNPVTSLSENYTCSD CCCCCCCCCCCCCCC | 24.46 | 21712546 | |
405 | Phosphorylation | VTSLSENYTCSDSEE CCCCCCCCCCCCCCC | 12.69 | 23663014 | |
406 | Phosphorylation | TSLSENYTCSDSEES CCCCCCCCCCCCCCC | 19.67 | 21955146 | |
408 | Phosphorylation | LSENYTCSDSEESSE CCCCCCCCCCCCCCH | 36.05 | 22167270 | |
410 | Phosphorylation | ENYTCSDSEESSEKD CCCCCCCCCCCCHHH | 27.28 | 22167270 | |
413 | Phosphorylation | TCSDSEESSEKDKLA CCCCCCCCCHHHHCH | 39.48 | 22167270 | |
414 | Phosphorylation | CSDSEESSEKDKLAI CCCCCCCCHHHHCHH | 52.53 | 23663014 | |
418 | Ubiquitination | EESSEKDKLAIPKRL CCCCHHHHCHHCHHH | 51.38 | 29967540 | |
428 | Phosphorylation | IPKRLRRSLPPGLLR HCHHHHHCCCCCHHH | 38.50 | 22167270 | |
438 | Phosphorylation | PGLLRRVSSTWTTTT CCHHHHHCCCEEECC | 21.90 | 19261611 | |
439 | Phosphorylation | GLLRRVSSTWTTTTS CHHHHHCCCEEECCC | 25.71 | 28857561 | |
440 | Phosphorylation | LLRRVSSTWTTTTSA HHHHHCCCEEECCCC | 21.23 | 28857561 | |
442 | Phosphorylation | RRVSSTWTTTTSATG HHHCCCEEECCCCCC | 17.85 | 26657352 | |
443 | Phosphorylation | RVSSTWTTTTSATGL HHCCCEEECCCCCCC | 21.45 | 28857561 | |
444 | Phosphorylation | VSSTWTTTTSATGLP HCCCEEECCCCCCCC | 16.04 | 28857561 | |
445 | Phosphorylation | SSTWTTTTSATGLPT CCCEEECCCCCCCCC | 17.80 | 28857561 | |
446 | Phosphorylation | STWTTTTSATGLPTL CCEEECCCCCCCCCC | 23.03 | 28857561 | |
448 | Phosphorylation | WTTTTSATGLPTLEP EEECCCCCCCCCCCC | 38.73 | 28857561 | |
452 | Phosphorylation | TSATGLPTLEPAPVR CCCCCCCCCCCCCCC | 49.12 | 28270605 | |
463 | Phosphorylation | APVRRDRSTSIKLQE CCCCCCCCCCEEEEC | 30.69 | 28857561 | |
464 | Phosphorylation | PVRRDRSTSIKLQEA CCCCCCCCCEEEECC | 35.05 | 28857561 | |
465 | Phosphorylation | VRRDRSTSIKLQEAP CCCCCCCCEEEECCC | 20.97 | 19261611 | |
467 | Ubiquitination | RDRSTSIKLQEAPSS CCCCCCEEEECCCCC | 43.83 | 21963094 | |
473 | Phosphorylation | IKLQEAPSSSPDSWN EEEECCCCCCCCCCC | 50.96 | 20068231 | |
474 | Phosphorylation | KLQEAPSSSPDSWNN EEECCCCCCCCCCCC | 44.85 | 25159151 | |
475 | Phosphorylation | LQEAPSSSPDSWNNP EECCCCCCCCCCCCC | 36.74 | 21815630 | |
478 | Phosphorylation | APSSSPDSWNNPVMM CCCCCCCCCCCCEEE | 34.78 | 21815630 | |
486 | Phosphorylation | WNNPVMMTLTKSRSF CCCCEEEEEECCCCC | 17.12 | 25627689 | |
489 | Ubiquitination | PVMMTLTKSRSFTSS CEEEEEECCCCCCHH | 47.16 | 21963094 | |
490 | Phosphorylation | VMMTLTKSRSFTSSY EEEEEECCCCCCHHH | 28.11 | 23403867 | |
492 | Phosphorylation | MTLTKSRSFTSSYAI EEEECCCCCCHHHHH | 39.71 | 19261611 | |
494 | Phosphorylation | LTKSRSFTSSYAISA EECCCCCCHHHHHHH | 20.29 | 25159151 | |
495 | Phosphorylation | TKSRSFTSSYAISAA ECCCCCCHHHHHHHH | 21.24 | 25159151 | |
496 | Phosphorylation | KSRSFTSSYAISAAN CCCCCCHHHHHHHHH | 18.61 | 23403867 | |
497 | Phosphorylation | SRSFTSSYAISAANH CCCCCHHHHHHHHHH | 14.02 | 21955146 | |
500 | Phosphorylation | FTSSYAISAANHVKA CCHHHHHHHHHHHHH | 17.10 | 28555341 | |
506 | Ubiquitination | ISAANHVKAKKQSRP HHHHHHHHHCCCCCC | 47.11 | 29967540 | |
511 | Phosphorylation | HVKAKKQSRPGALAK HHHHCCCCCCCCCCE | 49.69 | 28555341 | |
518 | Ubiquitination | SRPGALAKISPLSSP CCCCCCCEECCCCCC | 44.56 | 29967540 | |
520 | Phosphorylation | PGALAKISPLSSPCS CCCCCEECCCCCCCC | 21.05 | 25463755 | |
523 | Phosphorylation | LAKISPLSSPCSSPL CCEECCCCCCCCCCC | 35.30 | 22167270 | |
524 | Phosphorylation | AKISPLSSPCSSPLQ CEECCCCCCCCCCCC | 37.29 | 22167270 | |
527 | Phosphorylation | SPLSSPCSSPLQGTP CCCCCCCCCCCCCCC | 38.07 | 25159151 | |
528 | Phosphorylation | PLSSPCSSPLQGTPA CCCCCCCCCCCCCCH | 36.02 | 25159151 | |
533 | Phosphorylation | CSSPLQGTPASSLVS CCCCCCCCCHHHHHH | 11.61 | 25159151 | |
536 | Phosphorylation | PLQGTPASSLVSKIS CCCCCCHHHHHHHHH | 25.96 | 23403867 | |
537 | Phosphorylation | LQGTPASSLVSKISA CCCCCHHHHHHHHHC | 34.59 | 23403867 | |
540 | Phosphorylation | TPASSLVSKISAVQF CCHHHHHHHHHCCCC | 29.57 | 23403867 | |
541 | Ubiquitination | PASSLVSKISAVQFP CHHHHHHHHHCCCCC | 32.95 | 29967540 | |
543 | Phosphorylation | SSLVSKISAVQFPES HHHHHHHHCCCCCCC | 26.56 | 28555341 | |
550 | Phosphorylation | SAVQFPESADTTAKQ HCCCCCCCCCCCHHH | 31.51 | 21815630 | |
553 | Phosphorylation | QFPESADTTAKQSLG CCCCCCCCCHHHHHC | 28.50 | 21712546 | |
554 | Phosphorylation | FPESADTTAKQSLGS CCCCCCCCHHHHHCC | 32.19 | 21712546 | |
556 | Ubiquitination | ESADTTAKQSLGSHR CCCCCCHHHHHCCCC | 38.02 | 29967540 | |
558 | Phosphorylation | ADTTAKQSLGSHRAL CCCCHHHHHCCCCCE | 33.71 | 29214152 | |
561 | Phosphorylation | TAKQSLGSHRALTYT CHHHHHCCCCCEEEC | 18.32 | 21712546 | |
566 | Phosphorylation | LGSHRALTYTQSAPD HCCCCCEEECCCCCC | 24.44 | 23663014 | |
567 | Phosphorylation | GSHRALTYTQSAPDL CCCCCEEECCCCCCC | 12.02 | 23663014 | |
568 | Phosphorylation | SHRALTYTQSAPDLS CCCCEEECCCCCCCC | 15.71 | 23663014 | |
570 | Phosphorylation | RALTYTQSAPDLSPQ CCEEECCCCCCCCCC | 33.69 | 23663014 | |
575 | Phosphorylation | TQSAPDLSPQILTPP CCCCCCCCCCCCCCC | 23.34 | 23663014 | |
580 | Phosphorylation | DLSPQILTPPVICSS CCCCCCCCCCEEECC | 27.46 | 28270605 | |
586 | Phosphorylation | LTPPVICSSCGRPYS CCCCEEECCCCCCCC | 19.96 | 28270605 | |
587 | Phosphorylation | TPPVICSSCGRPYSQ CCCEEECCCCCCCCC | 19.04 | 28270605 | |
590 | Ubiquitination | VICSSCGRPYSQGNP EEECCCCCCCCCCCC | 31.17 | 29967540 | |
593 | Phosphorylation | SSCGRPYSQGNPADE CCCCCCCCCCCCCCC | 34.00 | 25159151 | |
597 | Ubiquitination | RPYSQGNPADEPLER CCCCCCCCCCCCHHH | 48.16 | 29967540 | |
601 | Ubiquitination | QGNPADEPLERSGVA CCCCCCCCHHHCCCC | 39.82 | 29967540 | |
613 | Phosphorylation | GVATRTPSRTDDTAQ CCCCCCCCCCCCCCE | 47.39 | - | |
615 | Phosphorylation | ATRTPSRTDDTAQVT CCCCCCCCCCCCEEC | 42.43 | 24144214 | |
618 | Phosphorylation | TPSRTDDTAQVTSDY CCCCCCCCCEECCCC | 23.07 | 24144214 | |
622 | Phosphorylation | TDDTAQVTSDYETNN CCCCCEECCCCCCCC | 12.10 | 24144214 | |
623 | Phosphorylation | DDTAQVTSDYETNNN CCCCEECCCCCCCCC | 39.06 | 24144214 | |
625 | Phosphorylation | TAQVTSDYETNNNSD CCEECCCCCCCCCCC | 25.15 | 27642862 | |
625 | Ubiquitination | TAQVTSDYETNNNSD CCEECCCCCCCCCCC | 25.15 | 29967540 | |
627 | Phosphorylation | QVTSDYETNNNSDSS EECCCCCCCCCCCCH | 36.70 | 24144214 | |
631 | Phosphorylation | DYETNNNSDSSDIVQ CCCCCCCCCCHHHCC | 40.78 | 24144214 | |
633 | Phosphorylation | ETNNNSDSSDIVQNE CCCCCCCCHHHCCCC | 29.72 | 24144214 | |
634 | Phosphorylation | TNNNSDSSDIVQNED CCCCCCCHHHCCCCC | 36.03 | 24144214 | |
634 | Ubiquitination | TNNNSDSSDIVQNED CCCCCCCHHHCCCCC | 36.03 | 29967540 | |
643 | Phosphorylation | IVQNEDETECLREPL HCCCCCHHHHHHHHH | 44.30 | 24144214 | |
654 | Phosphorylation | REPLRKASACSTYAP HHHHHHCHHCCCCCC | 32.61 | 25159151 | |
657 | Phosphorylation | LRKASACSTYAPETM HHHCHHCCCCCCCHH | 24.95 | 28270605 | |
658 | Phosphorylation | RKASACSTYAPETMM HHCHHCCCCCCCHHH | 24.48 | 26657352 | |
659 | Phosphorylation | KASACSTYAPETMMF HCHHCCCCCCCHHHC | 12.13 | 28270605 | |
663 | Phosphorylation | CSTYAPETMMFLDKP CCCCCCCHHHCCCCC | 16.93 | 29449344 | |
729 | Ubiquitination | MGLFEAFKIPIREFM CCHHHHCCCCHHHHH | 55.40 | - | |
766 | Ubiquitination | DVLHAVWYLTTQPIP HHHHHHHHHHCCCCC | 6.38 | 29967540 | |
798 | Ubiquitination | DSGFTHGHMGYVFSK CCCCCCCCEEEEEEE | 10.01 | 29967540 | |
912 | Ubiquitination | ILATDLKKHFDFVAK HHHHCHHHHHCHHHC | 57.72 | 29967540 | |
919 | Ubiquitination | KHFDFVAKFNGKVND HHHCHHHCCCCCCCC | 33.78 | 29967540 | |
923 | Ubiquitination | FVAKFNGKVNDDVGI HHHCCCCCCCCCCCC | 38.68 | 29967540 | |
947 | Ubiquitination | LVCQMCIKLADINGP EEEEHHHHHHHCCCC | 32.47 | 29967540 | |
956 | Ubiquitination | ADINGPAKCKELHLQ HHCCCCHHCCCHHCC | 49.31 | 29967540 | |
1003 | Phosphorylation | QLANLQESFISHIVG HHHHHHHHHHHHHHH | 18.21 | 25627689 | |
1030 | Phosphorylation | PGKWVEDSDESGDTD CCCCCCCCCCCCCCC | 29.76 | 24144214 | |
1033 | Phosphorylation | WVEDSDESGDTDDPE CCCCCCCCCCCCCHH | 47.13 | 25137130 | |
1036 | Phosphorylation | DSDESGDTDDPEEEE CCCCCCCCCCHHHHH | 45.91 | 25137130 | |
1054 | Phosphorylation | PAPNEEETCENNESP CCCCHHHHHCCCCCC | 28.53 | 24144214 | |
1060 | Phosphorylation | ETCENNESPKKKTFK HHHCCCCCCCCHHHH | 44.11 | 24144214 | |
1088 | Ubiquitination | QNHKMWKKVIEEEQR HCCHHHHHHHHHHHH | 32.69 | 29967540 | |
1103 | Phosphorylation | LAGIENQSLDQTPQS HHCCCCCCCCCCCCC | 45.56 | 22167270 | |
1107 | Phosphorylation | ENQSLDQTPQSHSSE CCCCCCCCCCCCCHH | 23.98 | 22167270 | |
1110 | Phosphorylation | SLDQTPQSHSSEQIQ CCCCCCCCCCHHHHH | 26.92 | 22167270 | |
1112 | Phosphorylation | DQTPQSHSSEQIQAI CCCCCCCCHHHHHHH | 40.60 | 22167270 | |
1113 | Phosphorylation | QTPQSHSSEQIQAIK CCCCCCCHHHHHHHH | 28.26 | 22167270 | |
1120 | Sumoylation | SEQIQAIKEEEEEKG HHHHHHHHHHHHHCC | 63.19 | 28112733 | |
1120 | Ubiquitination | SEQIQAIKEEEEEKG HHHHHHHHHHHHHCC | 63.19 | 29967540 | |
1136 | Phosphorylation | PRGEEIPTQKPDQ-- CCCCCCCCCCCCC-- | 55.69 | 20860994 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
292 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
293 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
312 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
312 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
428 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
428 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
438 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
438 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
465 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
492 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
568 | T | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PDE3A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PDE3A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
VATB2_HUMAN | ATP6V1B2 | physical | 22863883 | |
CSDE1_HUMAN | CSDE1 | physical | 22863883 | |
GANAB_HUMAN | GANAB | physical | 22863883 | |
GMPPB_HUMAN | GMPPB | physical | 22863883 | |
PLAK_HUMAN | JUP | physical | 22863883 | |
MMS19_HUMAN | MMS19 | physical | 22863883 | |
RNBP6_HUMAN | RANBP6 | physical | 22863883 | |
TRM1_HUMAN | TRMT1 | physical | 22863883 | |
UBE4B_HUMAN | UBE4B | physical | 22863883 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
112410 | Hypertension and brachydactyly syndrome (HTNB) |
Kegg Drug | |
D00227 | Aminophylline (USP/INN); Somophyllin (TN); Theophylline ethylenediamine (TN) |
D00231 | Amrinone (JAN/INN); Inamrinone (USP); Amcoral (TN) |
D00371 | Theophylline (JP16); Elixophyllin (TN); Quibron-t (TN); Theo-24 (TN); Theodur G (TN); Theolair (TN); |
D00417 | Milrinone (JAN/USP/INN); Milrila (TN) |
D00528 | Anhydrous caffeine (JP16); Caffeine (USP); Anhydrous caffeine (TN) |
D00718 | Flavoxate hydrochloride (JP16/USAN); Urispas (TN) |
D01133 | Pimobendan (JAN/USAN/INN); Acardi (TN) |
D01198 | Toborinone (JAN/USAN/INN) |
D01220 | Trapidil (JP16/INN); Rocornal (TN) |
D01385 | Ibudilast (JP16/INN); Ketas (TN) |
D01453 | Caffeine hydrate (JP16); Caffeine monohydrate; Caffeine (TN) |
D01630 | Propentofylline (JAN/INN) |
D01690 | Vesnarinone (JAN/USAN/INN); Arkin Z (TN) |
D01712 | Theophylline sodium acetate (JAN) |
D01771 | Proxyphylline (JAN/INN); Monophyllin (TN) |
D01896 | Cilostazol (JP16/USAN/INN); Pletal (TN) |
D02017 | Choline theophylline (JAN); Oxtriphylline (USP); Choline theophyllinate (INN); Theophyline - choline |
D02042 | Olprinone hydrochloride hydrate (JAN); Coretec (TN) |
D02084 | Inamrinone lactate; Inocor (TN) |
D02085 | Milrinone lactate; Primacor (TN) |
D02218 | Papaverine hydrochloride (JP16/USP); Pavabid (TN) |
D02933 | Anagrelide hydrochloride (USAN); Agrylin (TN) |
D04004 | Enoximone (USAN/INN); Perfan (TN) |
D04508 | Imazodan hydrochloride (USAN) |
D04529 | Indolidan (USAN/INN) |
D04628 | Isomazole hydrochloride (USAN) |
D04720 | Levosimendan (USAN/INN); Simdax (TN) |
D04751 | Lixazinone sulfate (USAN) |
D05429 | Aminophylline hydrate (JP16) |
D06103 | Theophylline (USP); Theophylline monohydrate; Accurbron (TN) |
D06104 | Theophylline sodium glycinate (USP); Asbron (TN) |
D06132 | Tibenelast sodium (USAN) |
D07089 | Moxaverine (INN) |
D07425 | Papaverine (BAN); Mesotina (TN) |
D07439 | Papaverine sulfate; Papaverine SAD (TN) |
D07455 | Anagrelide (INN/BAN) |
D07603 | Caffeine citrate (USP); Cafcit (TN) |
D07961 | Flavoxate (INN); Bladuril (TN) |
D08238 | Moxaverine hydrochloride; Certonal (TN) |
D08294 | Olprinone (INN) |
D09843 | Beradilol monoethyl maleate (JAN); TZC-5665 |
D10255 | Anagrelide hydrochloride hydrate (JAN); Anagrelide hydrochloride monohydrate |
DrugBank | |
DB01223 | Aminophylline |
DB01427 | Amrinone |
DB00261 | Anagrelide |
DB00201 | Caffeine |
DB01166 | Cilostazol |
DB04880 | Enoximone |
DB05266 | Ibudilast |
DB00922 | Levosimendan |
DB00235 | Milrinone |
DB01303 | Oxtriphylline |
DB00277 | Theophylline |
DB08811 | Tofisopam |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312 AND SER-428, ANDMASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-440, AND MASSSPECTROMETRY. |